Ignite Creation Date:
2025-12-24 @ 10:55 PM
Ignite Modification Date:
2026-03-12 @ 7:57 PM
Study NCT ID:
NCT05772169
Status:
COMPLETED
Last Update Posted:
2025-01-20
First Post:
2023-03-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Determine the Prevalence of Hypercortisolism in Patients With Type 2 Diabetes and Treatment With Korlym® (Mifepristone) (CATALYST)
Sponsor:
Corcept Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-31
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12-18
Completion Date Type:
ACTUAL
First Submit Date:
2023-03-06
First Submit QC Date:
None
Study First Post Date:
2023-03-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-17
Last Update Post Date:
2025-01-20
Last Update Post Date Type:
ACTUAL